Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 13,054	$ 9,522
General and administrative	4,912	3,248
Total operating expenses	17,966	12,770
Loss from operations	(17,966)	(12,770)
Other income	1,333	1,983
Loss before income tax expense	(16,633)	(10,787)
Income tax expense	0	0
Net loss	$ (16,633)	$ (10,787)
Net loss per share - basic and diluted (in dollars per share)	$ (0.12)	$ (0.08)
Basic and diluted weighted average shares outstanding (in shares)	138,236	136,608
Other comprehensive loss:
Net loss	$ (16,633)	$ (10,787)
Unrealized loss on marketable securities	(20)	(127)
Comprehensive loss	$ (16,653)	$ (10,914)